" 558.665 
zilpaterol. 
(a) specifications. type a medicated articles containing 21.77 grams (g) zilpaterol hydrochloride per pound. 
(b) approvals. see no. 000061 in  510.600(c) of this chapter. 
(c) tolerances. see  556.765 of this chapter. 
(d) special considerations (1) labeling shall bear the following caution statements: zilpaterol hydrochloride is not for use in animals intended for breeding. do not allow horses or other equines access to feed containing zilpaterol. do not use in veal calves. 
(2) labeling of type a medicated articles and type b medicated feeds used to manufacture complete type c medicated feeds shall bear the caution statements in paragraph (d)(3) of this section. 
(3) labeling of complete type c medicated feeds shall bear the following caution statements: not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. if pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. 
(4) type b liquid feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. the liquid type b feeds must be maintained at a ph of 3.8 to 7.5. for liquid feeds stored in recirculating tank systems: recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. recirculate daily as described even when not used. for liquid feeds stored in mechanical, air or other agitation-type tank systems: agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. agitate daily as described even when not used. 
(e) conditions of use in cattle. it is administered in feed as follows: 
zilpaterol in grams/ton combination in grams/ton indications for use limitations sponsor (1) 6.8 cattle fed in confinement for slaughter: for increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed feed continuously as the sole ration during the last 20 to 40 days on feed to provide 60 to 90 mg/head/day. withdrawal period: 3 days 000061 (2) 6.8 to provide 60 to 90 mg/head/day melengestrol acetate to provide 0.25 to 0.5 mg/ head/day heifers fed in confinement for slaughter: as in paragraph (e)(1) of this section; and for suppression of estrus (heat). as in paragraph (e)(1) of this section; see paragraph  558.342(d) of this chapter. melengestrol acetate as provided by nos. 000986 or 054771 in  510.600(c) of this chapter 000061 000986 (3) 6.8 to provide 60 to 90 mg/head/day monensin 10 to 40 cattle fed in confinement for slaughter: as in paragraph (e)(1) of this section; and for prevention and control of coccidiosis due to eimeria bovis and e. zuernii. as in paragraph (e)(1) of this section; see paragraph  558.355(d) of this chapter. monensin as provided by no. 000986 in  510.600(c) of this chapter. 000061 (4) 6.8 to provide 60 to 90 mg/head/day melengestrol acetate to provide 0.25 to 0.5 mg/ head/day heifers fed in confinement for slaughter: as in paragraph (e)(1) of this section; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii ; and for suppression of estrus (heat). as in paragraph (e)(1) of this section; see  558.342(d) and 558.355(d) of this chapter. monensin as provided by no. 000986; and melengestrol acetate as provided by nos. 000986 or 054771 in  510.600(c) of this chapter 000061 000986 (5) 6.8 to provide 60 to 90 mg/head/day monensin 10 to 40, plus tylosin 8 to 10 cattle fed in confinement for slaughter: as in paragraph (e)(1) of this section; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii; and for reduction of incidence of liver abscesses caused by fusobacterium necrophorum and arcanobacterum (actinomyces) pyogenes as in paragraph (e)(1) of this section; see  558.355(d) and 558.625(c) of this chapter. monensin as provided by no. 000986; tylosin as provided by nos. 000986 or 016592 in  510.600(c) of this chapter 000061 016592 (6) 6.8 to provide 60 to 90 mg/head/day. monensin 10 to 40, plus tylosin 8 to 10, plus melengestrol acetate to provide 0.25 to 0.5 mg/ head/day. heifers fed in confinement for slaughter: as in paragraph (e)(1) of this section; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii ; for reduction of incidence of liver abscesses caused by fusobacterium necrophorum and arcanobacterium (actinomyces) pyogenes ; and for suppression of estrus (heat). as in paragraph (e)(1) of this section; see  558.342(d), 558.355(d), and 558.625(c) of this chapter. monensin as provided by no. 000986; tylosin as provided by nos. 000986 or 016592; and melengestrol acetate as provided by nos. 000986 or 054771 in  510.600(c) of this chapter 000061 000986 016592 (7) 6.8 to 24 cattle fed in confinement for slaughter: for increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed feed continuously to cattle during the last 20 to 40 days on feed to provide 60 mg zilpaterol hydrochloride per head per day. withdrawal period: 3 days 000061 (8) 6.8 to 24 monensin 10 to 40, plus tylosin 8 to 10 cattle fed in confinement for slaughter: for increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter during the last 20 to 40 days on feed; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii; and for reduction of incidence of liver abscesses caused by fusobacterium necrophorum and arcanobacterium actinomyces pyogenes feed continuously to cattle during the last 20 to 40 days on feed to provide 60 mg zilpaterol hydrochloride per head per day. see paragraphs  558.355(d) and 558.625(c). monensin and tylosin as provided by no. 000986 in  510.600(c) of this chapter. withdrawal period: 3 days 000061 

